Providing ABA 1-to-1 therapy in your home
Offering social skills training and groups
Supplying community-based training
Supplying prevocational training at an early age
Providing parents and family members with training, too
EDITOR’S LETTER
The Influence of Impact. The Architecture of Modern Health
DearReaders,
Inthehealthcaresector,‘influence’isatermweshouldhandlewithcare.It’snotaboutmarketshare, mediamentions,orthesheersizeofanorganization.Trueinfluenceisaboutshapingtheveryfabricofcare delivery,improvingoutcomes,andbuildingsystemsthatareasresilientastheyarecompassionate.It’sthe abilitytomakeatangible,positiveimpactonthehealthofpopulations.Itisthisspecific,potentformof leadershipthatweexploreinourannualedition,“TopMostInfluentialLeadersinHealthcare,2025.”
Ourcoverstory,FatimaGuillen,CEOofMCIGroup,offersamasterclassinthisphilosophy Thefieldof healthcareriskmanagementis,byitsnature,analyticalanddata-driven.Yet,Fatima’sextraordinary effectivenesscomesfromaprofoundlycounterintuitiveinsight:themostaccurateriskassessmentbegins withpeople.Herthreedecadesofhands-onexperienceininternationalmedicalassistancegavehera granularunderstandingofthehumanvariablesthatspreadsheetsoftenmiss.Shedidn’tlearntheindustry fromatextbook;shelearneditbyleadingteamsandmakingcriticaldecisionsontheground.AsCEO,she nowtranslatesthatdeep-seatedempathyintocorporatestrategy,provingthatthemostdurablesystemsare thosebuiltonafoundationofhumanunderstanding.Herleadershipisn’tjustaboutmanagingrisk;it's aboutmasteringitwithawisdomthatdataalonecannotprovide.
Thisissuealsohighlightsotherkeyarchitectsofchangewhoareredefiningtheirrespectivefields.We spotlighttheworkofMenzoHavenga,whoseleadershipatBataviaBiosciencesisacceleratingthe developmentofcriticalvaccinesandbiopharmaceuticals;MortenOlesen,afoundingpartneratCIMS, whoprovidesessentialstrategiccounseltotheindustry;KevinGoodwinofEchoNous,whoisplacing high-performanceultrasoundtechnologyintothehandsofmoreclinicians;andJoseMichan,whose visionatLifelightGroupiselevatingthestandardofseniorlivingandcare.
Theseindividualsdemonstratethatthemostsignificantadvancesinhealthcarearedrivenbythosewhocan successfullymergeinnovationwithintuition.Theyaren'tjustleadingcompanies;theyarerecalibratingour entireapproachtohealth,provingthatthemostlastinginfluenceisthekindthatgenuinelyserves humanity.
PANKAJ GHOLAP MANAGING EDITOR
EDITOR-IN-CHIEF
PUBLISHER VIKRAM
MANAGING
FATIMA GUILLEN
Fatima GUILLEN
Redefining Risk Management with Empathy and Innovation
Vision without action is just a wish. ‘‘
Cover Story
Healthcare
riskmanagementisadisciplinerootedindata,regulation,and financial models, essential for quantifying uncertainty, minimizing losses, and ensuring stability within systems responsible for human well-being. However, speaking with Fatima Guillen, the CEO of MCI Group, reveals that for some leaders, the most effective strategies in this complex field begin not with spreadsheets, but with a fundamental understandingofpeople.
Her approach, developed over three decades in international medicalassistance,indicatesthatmasteringriskinhealthcare requires a unique combination of sharp analytical skills and deepempathy.Inaworldincreasinglyreliantonalgorithms, Fatima argues for the indispensable value of the human element.
ThisstoryexploreshowFatimaGuillen’sdistinctivepathand guidingphilosophyhavepositionedherasakeyinfluencerin reshapingtheglobalapproachtohealthcareriskmanagement.
TheUnconventionalTrainingGround:Buildinga Human-CentricView
Fatima’s professional trajectory did not follow the conventional pipeline to a CEO position in international financeorhealthcareadministration.Hereducationaljourney began in a field focused entirely on human development: Education,followedbyMaster'sdegreesinPsychopedagogy and Pedagogy. This was not a detour; it was, in her description,“adeliberatepursuitofknowledge,”drivenby “a restless curiosity.” This foundational work in understandinghowpeoplelearn,think,andinteractappears, inretrospect,asanalmostideal,ifunexpected,preparationfor navigating the human complexities inherent in medical assistanceandclaimsmanagement.
She consciously broadened this base, adding layers of understanding crucial for global business. A Master’s in International Relations provided the geopolitical context, while further specialization in finance added the necessary command of economic systems This multidisciplinary backgroundresultedinaprofilethat,assheputsit,“bridges the human, the strategic, and the global.” It equipped her notjustwithtechnicalskills,butwithararecapacitytoview intricateinternationalhealthcarechallengesthroughmultiple, interconnectedlenses.
DecadesForgingExpertiseinaGlobalArena
Stepping into the international medical assistance sector, Fatima spent over 30 years immersed in its realities.Theseweredecadesspentnotindetached oversight, but actively “leading teams, building projects, and making decisions that expanded our reach and deepened our impact.” This extensive, hands-on experience across diverse international contexts provided her with an intimate, nuanced understanding of the industry’s evolution,itsinefficiencies,anditsinherentrisks–knowledge that cannot be gained from textbooks alone. Each phase of this journey, she reflected, “shaped the leader I am today,” preparing her for the responsibility of guiding MCI Group, which nowencompassesMedicalClaimsInternational, MCI Assist, MCI Finance, and the strategically significantMCILatam
As CEO, her role involves defining the trajectory for the entire group, ensuring “sustainable growth” and strengthening MCI Group's position as a global leader in medical assistance and cost containment. But she emphasizes the human dimension of her leadership: “I don’t just define the strategy I live it.” This means actively guiding, supporting, and empowering the people who translate that strategy into action. It requires “making bold decisions,” yes, but also “staying closetotheteamswhoexecutethemwithheart.”
EmpathyasaStrategicAsset:TheMCIGroup Approach
At its core, MCI Group provides integrated solutions in international medical claims management, healthcare assistance, cost containment,andfinancialservicestailoredtothe healthcare sector. These are critical functions requiring precision and efficiency. Yet, Fatima believes their distinctiveness lies in their operational philosophy “What truly differentiatesusisn’tjustwhatwedo—it'show wedoit,”sheexplained.
This “how” is defined by a profound commitment to recognizing the individual within the process. “At MCI, every claim is a story. Every case, a person,”shestated.Thisperspectivemandatesthat they“leadwithempathy—always.”
Cover Story
Leadership isn’t volumeit’s vision. It’s listening with intention, acting with conviction, and building legacies where others can thrive long after you’re gone.
Cover
Story
Thishuman-centeredphilosophyisnotamereadd-on;itis a strategic element that builds trust. Their cultural alignment across diverse regions, transparent processes, andoperationalefficiencyareallbuiltonthisfoundationof trust,which“resonateswithclientsacrosstheglobe.”In riskmanagement,whereclearcommunicationandtrustare paramount to accurate claims processing and fraud prevention,leadingwithempathybecomesapowerfultool.
InnovationinAction:Digital,Proximity,andPillarsof Efficiency
Innovation at MCI Group focuses on leveraging technology and strategic presence to improve healthcare assistanceandriskmanagementglobally Akeypriorityis digital transformation, but executed with a clear human focus. They are “building systems that are digital by design, but human at heart,” investing in technology without losing essential human connection. They also invest heavily in continuous learning, recognizing that “knowledge is our best compass” in a fast-changing industry
A recent, pivotal strategic move demonstrating this blend of vision and practicality was the inauguration of MCI Latam in Puerto Plata, Dominican Republic, on May 1st. For Fatima, thiswas“oneofthemostemotionalmilestonesin my career,” witnessing a “spark” and the sense of “igniting a new era.” This center was designedtoservetheentireAmericancontinent, successfully replicating MCI Group’s established30+yearmodelfromSpain.
The strategic rationale was clear: gaining “cultural, linguistic, and operational proximity” to clients in the Americas For Fatima,thisproximityhasadeepersignificance. “Proximity saves lives,” she asserted, underscoring her belief in the importance of bringingsolutions“wheretheymattermost:on the ground, by your side.” This expansion is a direct application of her philosophy that being closer to the human need improves service and riskmanagement.
MCI Group employs a robust strategy to ensure transparent, accurate, and efficient claims processingwhileactivelyreducingcosts,builton threekeypillars:
First,Technology-drivenmedicalcontrol This involves deploying automated systems for auditing and reviewing medical bills, using technology to ensure precision and detect potentialerrorsoroverbilling.
Second, an Optimized provider network This means cultivating long-term partnerships with medical providers through “active listening, mutual respect, and long-term commitment.” Theserelationships,builton“fairagreements,” ensure quality care is delivered efficiently without unnecessary excess. They treat every provider “as a partner,” fostering dialogue and collaboration rather than simply relying on oversight, because “Consistency in quality comes from connection, not control.” This partnership model is vital for navigating the complexities of international provider networks andmanagingriskeffectively.
Third, Ongoing training for their teams. This ensuresstaffareequippedtomakedecisionsthat are not just fast and informed, but also “compassionate ” Fatima emphasized that in healthcare, “time and trust are as critical as cost,” highlighting how a well-trained, empathetic team can balance these crucial elementsforbetteroutcomesandreducedrisk.
EarningInfluenceandChartingtheFuture
Leadingaglobalcompanyinatechnicalindustry, particularly as a woman, presented challenges whereher“voicewasn’tautomaticallyheard.” Fatimanavigatedthesebycombiningherdiverse background with strategic action: “education, performance, and emotional intelligence” were keytoearningrespectand,critically,influence.
She approaches opportunities with a mindset of “making hay while the sun shines”—being ready to act with passion and speed when opportunity appears” when they appear – a proactive stance that “has unlocked doors that onceseemedsealed.”
Asked about innovation with unlimited resources, she identified three transformative areas for improving global healthcare risk management:
● Investing in Medical AI to detect overbilling, errors, and provide real-time insights for care optimization – a direct technologicalenhancementtoclaimsriskmanagement.
● Scaling Global health education to empower patients with accessible, actionable knowledge – addressing risk through preventionandinformeddecision-making.
● Building Collaborative global networks to connect insurers, hospitals, and platforms for ethical data, best practices, and resource sharing – creating a systemic approach to managing riskthroughsharedintelligence.
MCI Group is actively working towards this future. They aim to positionMCILatamasaflagshipintheAmericas,asymboloftheir agility, proximity, and trustworthiness. They are “forging partnershipswithAIinnovatorsandmedicalaudittechfirms,” investinginthetechnologicaladvancementsshebelievesarecrucial. Future growth includes expanding their network of insurers in the Americas and Mediterranean and entering new regions, always holdingfirmtotheprincipleofnevercompromising“onthehuman essenceofourservice.”
FindingCenterinaDemandingWorld
Leading at this level requires deliberate effort to maintain balance. Fatimafindsclarityinpause,seeingdowntimenotassteppingaway, but as stepping back in “with greater purpose.” She recharges through reading, classical music, traveling, and spending quality timewithherfamily–activitiesthatprovideessentialresetandnew perspectives. Engaging in cultural and social initiatives keeps her grounded and connected, reinforcing her conviction that “true leadershipisrootedinawarenessandempathy.”
Her leadership philosophy is encapsulated in Mahatma Gandhi’s words: “The future depends on what you do today.” She views leadershipas“anactofservice,vision,andcourage.”Witnessing the MCI Latam inauguration, she saw a “long-held dream come to life” through the team’s dedication, a potent reminder that “vision without action is just a wish.” For Fatima Guillen, effective leadership in healthcare risk management means visionary action, listening with intention, acting with conviction, and building legaciescenteredonhumanwell-being.
Live with Purpose
A Life With PURPOSE is a LIFE FULFILLED.
Skilled Nursing
Rehabilitation Services
Assisted Living
Dialysis
Home Care
Unleashing Innovation in Healthcare with Telemedicine JOSE MICHAN
Inthefast-pacedrealmofhealthcare,where innovationisthekeytosuccess,JoseMichanstands tallasatruetrailblazer AstheCEOofLifelight Group,hehasrevolutionizedhowmedicalservicesare delivered,breakingbarriersandmakingqualityhealthcare accessibletopeopleworldwide.
Michan'sjourneytobecomingaprominentfigureinthe healthcareindustryisatestamenttohisdedicationand expertise.Withover20yearsofexperienceinmedicine, health,telemedicine,pharmaceuticals,andhospital management,hehashonedhisskillsandcarvedaniche.A HarvardMedicalSchoolgraduatewithafellowshipin GastroenterologyandanalumnusofthePritzkerSchoolof MedicineattheUniversityofChicago,Michan'sacademic achievementsspeakvolumesabouthiscommitmentto excellence.
AtthehelmofaconglomeratethatincludesLifelight Medical,LifelightWeightLoss,LifelightHairRecovery, LifelightPharma,LifelightStore,andthegroundbreaking Meurgedoc,Michanhasspearheadedatransformative telemedicineproject.Thisinnovativeendeavorseamlessly connectspatientswithtop-notchmedicalspecialists worldwideatthemereclickofabutton,breakingdown geographicalbarriersandensuringaccesstothebest healthcareprofessionalsregardlessoflocation.
TheimpactoftheCOVID-19pandemichaspropelledthe healthcareindustryforwardbyleapsandbounds,with telemedicineemergingasagame-changer.Michan's proactiveleadershiphaspositionedLifelightGroupand MeurgedocasleadingtelemedicineprovidersofLatin America,bringingqualityhealthcaretoeventhemost underservedcommunities.Today,theoverarchinggoalof Michanandhisventuresistomakequalityhealthcare availablegloballywithasingleclick,revolutionizinghow medicalcareisdelivered.
InadditiontohisroleastheCEOofLifelightGroup, Michanalsomanageshisprivatemedicalpractice, specializingininternalmedicine,gastroenterology, andbariatriccare.Hiscommitmenttoimproving healthcareextendsbeyondhisbusinessventures,as heservesasthedirectoroftheLifelightFoundation. Throughthisorganization,hefocusesoncritical areassuchasnutrition,obesity,diabetes,and metabolicsyndrome.Heutilizestop-of-the-line telemedicinetechnologyandmobileclinicsto providevitalmedicalservicestounderservedrural regionsofMexico.
LifelightGroup:CommittedtoInnovatingWith Purpose
Sinceitsestablishmentin2005,LifelightGrouphas emergedasaleadinghealthcareproviderdedicated torevolutionizingthemanagementofoverweight andobesity Withacomprehensiveapproachto healthcareandacommitmenttoinnovation, LifelightGroupcontinuestosetnewstandardsin medicaladvancements.
LifelightGroup'smissionissafeguardingpatients, healththroughimplementingthebestclinical practices.Theorganizationcontinuouslydevelops, evolves,andinnovatesinhealthcaredelivery,all withthesingularobjectiveofenhancingthequality ofpeople'slives.Moreover,LifelightGroupseeksto makealastingsocialimpactinMexicoandtheUSA, goingbeyondprograminnovationandstrivingto createpositivechangeinthecommunitiesthey serve.
Guidedbycorevalues,includinghonesty,loyalty, equality,equity,andethics,LifelightGroupupholds highethicalstandardsinallitsoperations.
Thesevaluesformthefoundation thatguidesthecompanytoward achievingexcellenceandensures thatitsactionsalignwithits commitmenttointegrity
CentraltoLifelightGroup’s offeringsistheirsuperiorservices andsolutionsthatsetthemapartin theindustry.Fromthe groundbreakingtelemedicine programMeurgedoctoOnline WeightLosswithMeurgedieta, LifelightWeightLossclinics, LifelightHairRecoveryclinics, andanarrayofVitaminandWeight LossproductsattheLifelight Store,thecompanyprovidesa comprehensivesuiteofhealthcare optionstoitspatients.Moreover, theirmobileclinics,equippedwith satelliteconnections,ensurethat medicalassistancereacheseventhe mostremoteareas.
LifelightGroup’scommitmentto technology-drivenhealthcareis evidentthroughitsseamless integrationoftelemedicineintoits
services.Theyhaverevolutionized medicalcarebyembracing telemedicine,makingiteasily accessiblewithasimpleclick.This breakthroughenablespatientsto receivetimelyandefficientmedical attentionfromthecomfortoftheir ownhomes,eliminatinggeographical barriers.
Furthermore,LifelightGrouphasa dedicatedmedicalresearchdivision focusedonweightlosstreatments, gastrointestinalintolerance,and immunoglobulinallergytreatments. Thiscommitmenttoongoingresearch ensuresthatitsservicesremainatthe forefrontofmedicaladvancements, providingpracticalsolutionsfor needypatients.
Patient-CentricApproach: ImprovingLivesthroughMedical Consultations
JoseMichanplaysavitalrolein LifelightGroupbymanagingitsteam andoverseeingitsgrowth.He providesconsultationsoninternal
“Think of the problem as an opportunity to change, serve and improve.” “
medicine,gastrointestinal,and bariatricmedicine,staying currentwiththelatest advancements.Hisgreatest satisfactioncomesfrom interactingwithpatientsand positivelyimpactingtheirlives. Honestyiscrucialtohim,andhe encourageshisemployeesto speakupandaddressany concernsopenly,regardlessof theirmagnitude.Hebelieves fosteringacultureoftrustand transparencyiskeyto overcominganyobstacle.
NurturingaStrongteamwith InnovationandCreativity
Michanbelievesthathealthcare leadersintoday’sdynamic environmentshouldpossess essentialqualitiessuchasbeing goal-orientedandhavinghigh emotionalintelligence.Effective leadershiprequiresunderstanding ourworld'sdiversityandadrive totakeactionandcreatelasting positivechange.
Incontrasttoabosswhomerelymanages subordinates,atrueleaderempowerstheirteamto reachtheirfullpotential.Michanprioritizesauthentic leadershipbyinspiringhisemployeestoinnovate, thinkcreatively,andpursueexcellence.Herecognizes thathisteamneedsaleaderwhoguidesthemtoward greatness.
TelemedicineandConnectivity:EnablingUniversal AccesstoHealthcare
JoseMichanenvisionsapromisingfutureforthe healthcareindustry,drivenbythreekeytrends.Firstly, hebelievesintheimportanceofensuringdiverse healthcareoptionsatalllevels,makingitaccessibleto peopleacrossallsocioeconomicbackgrounds.To achievethis,heenvisionsleveragingtechnologiessuch asTelemedicine,satelliteconnections,andtheInternet.
Recognizingtheneedforinclusivehealthcare, LifelightGrouphasembarkedonasignificant initiativecalled“HealthwithoutBorders.”This pioneeringprogramaimstoprovideLatin-American immigrantsintheUSAandCanadawithspecialty medicalconsultationsthroughouttheregion.Lifelight Groupstrivestobridgethegapandofferhealthcare servicestothosemostneedingthembyutilizingbrandnewTelemedicineMobilemodulesandclinics.
LifelightGrouppreparestonavigatethehealthcare landscapeforthenextcenturybyembracing innovationandstayingabreastofthelatestmedical research.Withacommitmenttomeetingtheevolving needsofpatients,JoseMichan'sleadershipensuresthat thecompanyiswell-equippedtoleverageemerging trendsandcontributetothetransformativefutureofthe healthcareindustry
BalancingSuccess:ApproachtoWork-LifeHarmony
JoseMichanprioritizeshisprofessionalandpersonallife, maintainingaperfectbalance.Oneofhispassionsisflyingasa privatepilot,whichgiveshimasenseoffreedom.Healsoenjoys readingliteraturethatbroadenshisknowledgeandperspective. Michancaresforhisphysicalwell-beingbydedicatingtimeto exercise,ensuringmentalandphysicalfitness.Additionally,he contributeshismedicalexpertisetounderservedcommunitiesby collaboratingwithDoctorswithoutBorders.
WiseAdvice
Foraspiringentrepreneursandbusinessleadersventuringinto thehealthcareindustry,JoseMichanofferssomevaluableadvice. Heemphasizestheimportanceofsettingcleargoalsand maintainingafocusedmindset.Understandingwhatyouaimto achieveandaccomplishiscrucialinnavigatingthiscomplex industry
Additionally,Joseencouragesaspiringleaderstoseek mentorship.Manyexperiencedhealthcareprofessionalsare willingtosharetheirknowledgeandguidancewiththenext generation.Byjoiningamentorshipprogram,aspiring entrepreneurscanbenefitfromtheinsightsandexpertiseofthese seasonedleaders.
Josealsostressestheneedforyoungleaderswhoarewellpreparedforthefutureofmedicine.Thehealthcareindustryis constantlyevolving,requiringindividualsequippedwiththe latestknowledgeandskillstoaddressthechallengesand opportunitiesthatlieahead.
THEPARADOXOFPROGRESS Why More Money (Alone) Won’t Fix WOMEN’S HEALTH
Weseetheheadlines.Recordfunding.Venture capital,finally,wakinguptotheenormous, underservedmarketthatiswomen’shealth. Lastyear,2024,sawapeak:$2.6billionflowingin.That's upfrom$1.7billionin2023.Greenshoots,indeed.
Themoneyisn’tjustchasingappsanymore.Asolidthird ofit,we’retold,isnowtargetingbiopharma.Realscience. Treatmentsformisunderstood,oftendebilitatingconditions likeendometriosis,polycysticovariansyndrome.A genuineefforttotacklepreeclampsia,athreattomothers andbabiesthatwe’vetoleratedfortoolong(hattipto companieslikeComancheBio,pullingin$75million).
There’sevenadawningrecognitionthat“women’shealth” isn’tjustaboutreproduction.It’sabouthowautoimmune diseases,heartconditions,bonedisease–majorrevenue driversforpharma–uniquelyimpacthalfthepopulation. Thescope,asanSVBanalystrightlypointedout,is growing.Andabiggerscope,logically,shouldpainta brighterpicture.
But.
Andit’sasignificant“but.”
Moneyflowswhereitseesapath.Innovation,especially thefoundationalkind,thekindthatleadstobreakthrough drugs,oftensproutsinthesoilofacademia,nurturedby publicinvestment.
Andthat’swheretheparadoxkicksin.
ThepreviousBidenadministrationlaunchedtheWhite HouseInitiativeinWomen’sHealthResearch A necessarystep.$113milliondistributed.Butitwaslatein thegame.AsProfessorSabraKleinfromJohnsHopkins starklyputit,“Bythetimeitgotgoing,theylostthe election—andit’sover.”Ayearisn’tdedication.It’sa nod.
Now,considerthecurrentlandscapeunderPresidentTrump. Thesignalsare,shallwesay,mixed.Concerning,even. We’rehearingaboutslashedgrantfunding.MajorNIH studies,likethedecades-longWomen’sHealthInitiative–a bedrockofdataonmenopause,osteoporosis–sawitsfederal fundingthreatened,thenputinlimbo.Whenyou’realready dedicatingapaltry8.8%ofNIHresearchfundingtothe healthof51%ofthepopulation(astatisticfromtheNational Academiesthatshouldmakeusallpause),canyouafford any slowdown?DaréBiosciences’CEO,SabrinaJohnson, doesn’tmincewords:“Thefieldofwomen’shealthisalready underserved,sowecan’treallyaffordfurtherslowdown.”
Thenthere’sthechillingeffectofpolicy TherollbackofDEI initiatives,theinsistenceonacknowledgingonlytwosexes–thesearen’tjustsemantics.Theycreatebureaucratichurdles, theydiscourageresearchthatdoesn’tfitanarrowmold,and theycertainlydon’thelpafieldthat,until1993,wasn’teven requiredtoincludewomeninNIH-fundedclinicaltrials.We havedecadesofinformationdeficittoovercome.
Anditripples.CutsatHealthandHumanServices,evenif positionedasnotaffectingfrontlinereviewersattheFDA, createuncertainty.Foranindustrylikewomen’shealth,with relativelyfewproductshistoricallynavigatingtheFDA,any disruption,anyperceptionofslowdown,ismagnified.
So,what’stherealstoryhere?
Isittheoptimisticglowofventurecapitalfinallyseeingthe light?Orisittheflickering,uncertainflameoffoundational research,buffetedbypoliticalwinds?
Thetruthis,it’sboth.Andthat’stheproblem.
Privatecapitalisessential.Itfuelsgrowth,itbringsproducts tomarket.Butitrarelyfundstheriskiest,earliestscience. Thekindofsciencethat’s“underfunded”and“underacknowledged,”asexpertslikeMarcelleCedarsfromUCSF highlight.
Ifthepipelineofacademicresearch–the wellspringoffutureinnovation–isdecimated overfouryears,itwon’ttakefouryearsto rebuild.Itwilltakedecades Werisklosingnot justresearchers,butourstandingasleadersin biomedicalinnovation.
Thisisn’tjustabout“women’shealth.”It’sabout ourapproachtohealth,period.It’saboutwhether we’rewillingtomakesustained,long-term investmentsinthewell-beingof everyone
Theprivatesectorseesanopportunity.That’sgood.Butthis momentmightalsobeastarkcall:acallforprivatecapitalto considersteppingfurtherupstream.Toinvestintheriskier, foundationalsciencethatthepublicsectorseemsincreasingly hesitant,orunable,toconsistentlychampion.
Becausewithoutthatfoundationalscience,therecordventure capitalchecksoftodaymightjustbefundingyesterday’s ideastomorrow.
Andthat’saparadoxwecan’tafford.
Kevin Goodwin
(CEO
-ECHONOUS)
Redefining Healthcare Industry with AI’s Excellence
Thecontinuouslychanginghealthcareandscape requiresleaderstobedynamicaswellas proactive.Tooutsmartthecompetition,Leaders mustbeabletohandlethepresentwhilealso calculating thefuture,comprehendingthepossibilities,anddealing withlegislation.Asthe healthcaresectorisheavily regulated,ahealthcareleaderfacesintensescrutinytoday.
Risingabovetheodds,KevinGoodwin,theCEOof EchoNoushasinculcatedthequalities requiredtobean excellentleaderinthehealthcareindustry.Kevinhas beenintheglobalultrasoundbusinessfor34yearsand hasworkedincommercialhealthcarefor41years.He hasbeenaleader,innovator,andstudentof“pointofcare ultrasound”(POCUS)for morethan20years.
SteppingStones
Kevindecidedtopursueacareerinhealthcareinhigh schoolafterhismentortoldhim:“You’ll always have a job because healthcare is a booming business, it’s always going to be needed.” Heenteredcollegeintendingto majorinHospitalManagement,butaftercompletinga year-longinternshipatanearbyhospital,hechangedhis mindandchosetoworkintheprivatesector.Kevin beganworkingforAmericanHospitalSupplyrightoutof college,enteringtheworldofcommercialhealthcare, privatesitehealthcare,andcorporatedeliveryofgoods andservices.Fouryearslater,hequitthatorganization andjoinedPictureInternational.
Atthattime,importanttoolswereaccessible,nuclear scanningwasexpanding,andMRI,CTscanning,and ultrasoundwereallexperiencingrenaissance.Kevingot intotheultrasound businessin1987andworkedfora companynamedATL.HeeventuallyrelocatedtoSeattle totakethepositionofDirectorofTraining,andafter workingcloselywiththeCEO,hewasnamedtheheadof ultrasound.Thefirsttoofferpoint-of-careultrasoundwas formed.POCUSiswhatSonositecreatedandled.
InaugurationofEchoNous
AftersellingSonositein2012,KevinfoundedEchoNous afewyearslater.EchoNoushasprovedovertimeto becomethemarketleaderintheminiaturizationofhighqualityultrasound.ThepurposeofEchoNousistouse computervision,machinelearning,anddeeplearningto improvetheuseofultrasoundtechnologyinhealthcare. Thecompanystrivestouseahighlyinnovativehardware platformthatcanbecarriedbyhandandhasthe performanceandfunctionalityofamuchbigger,more expensivedevice.
EchoNoushastakentheleadershippositionofapplying deeplearning,machinelearning,and computervisionto howallultrasounddevicesareusedfromfronttoback. Forteacherstudentcommunication,thecompanyhas softwarethatautomatesqualityassuranceandcoaching. Theparadigmofwhatcanbedonewithhand-carried ultrasoundequipmenthasbeencompletelydismantledby
EchoNous’Kosmoshardware.Itimagesincrediblywell, andmoredoctorsarelearningthiseachpassingday With itsmanylayersofAI,EchoNous focusesonimage acquisition,whichisthemostdifficultaspectof ultrasoundduetouser dependence,imageinterpretation, logicalcalculations,anddecision-makingattheend.
ImpactfulandReliableServices
WiththehelpofEchoNous,healthcareorganizationsand othercompaniesthatmakevalves cannowuncover peoplewhoareasymptomaticbutneverthelessillwith conditionslikeheart failureandvalvediseaseand identifytheirsymptomsbeforetheybecomevisible.One of EchoNous’mostnotableservicesandsolutionsisa mixofhigh-qualitytechnologythat enablescliniciansto strolltothepatient'sside,bedside,orwhereverthepatient maybeand receiveaqualityimagemorequicklywithAI assistance.
Thisisthefirsttimeinthemedicalhistoryofultrasound thatadiseasecanbefoundbefore symptomsappear.The equipmentusedbyEchoNousissufficientlyreliableto completethe task,butitisalsoaffordable,simpleto operate,highlyautomated,andAI-affected.This device
hasopenedupanewwindowofopportunityforreal, authenticpublichealthandearly diseasediagnosis, amongotherthings,forheartfailurewithintactejection fractionandother valveconditions.
ResponsibilitiesandCopingMechanism
AsCEO,Kevin’sprimaryroleistogeneratecapital, guidethefirmtowarditsstrategic objectives,andhelpit becomethebestitcanbewhilecreatingabusiness model.ItisKevin whokeepsanideaofwhatthatmodel willentailandcertainguidingprinciplesinmind.This includesincreasinggrossmargins,revenuegrowth,and ultimatelyprofitmargins.Thetwo maingoalsofthis initiativearetoraisemoneyandhirehighlyqualified personnelatalllevels oftheorganization.
Kevinbelievesthatleadersinallfieldsneedtolookafter theirphysical,mental,emotional, andspiritualwellbeing.Leadersoughttobecapableoflookingafter themselves.Hebelievesthattosustaininthelongrun, live,andprosper,isthechallengeyoumustconcentrate on everyday.Heworksoutalotanddoesyogatwicea weektostayproactiveandmaintainahealthywork-life balance.Everyevening,heallowshimselfsome
downtimeandsteersclear of80-hour workweeks.Hearguesthatinvestingin restandrecuperationatnight,for instanceonweekends,isjustascrucialas engagingineffortandhardlabor
BrightFuturewithAI
AccordingtoKevin,abusinesslike EchoNouswouldupendthemiddle marketforultrasound equipment,which consistsoflargerdevices,withitslowcost,high-performanceproduct. EchoNous’sequipmentperforms similarlytothosemiddle-market machinesintermsofsize.
Themachine’smeasures,includingthose forimaging,Doppler,bloodflow velocity,and otherAIparameters,areall onparwiththoseoflargemachines.
KevinbelievesdeeplearningandAIhave agreatchancetoautomatethelabordone by caregiversandmakelearningquicker andsimpler.AIwillreducetime,enhance accuracy, andincreasetheamountof physicianandcareprovidertime availableforpatients,whilethe company’shardwarewillsavebothtime andmoney AccordingtoKevin, “EchoNous is not just planning for the future but also fostering the future that healthcare requires.”
“TO SUSTAIN IN THE LONG RUN, LIVE, AND PROSPER, IS THE CHALLENGE YOU MUST CONCENTRATE ON EVERY DAY.”
The Silent Killer of Patient Loyalty Your Antiquated Contact Center
Youjustspent$50milliononanewsurgical wing.Youhavethelatestdiagnosticimaging technology,andyourchiefofsurgeryisa regionalstar Thismorning,apotentialnewpatient,a womanwithexcellentinsurance,triedtoschedulea consultationwiththatstarsurgeon.
Afternavigatingaconfusingphonemenu,shewaitedon holdforsevenminuteslisteningtoadistortedVivaldi loop.Shewasthentransferredtothewrongdepartment, whereshehadtotellherstoryforasecondtime.Annoyed, shehungup.ShethenGoogledyourtopcompetitor,found a“ScheduleOnline”button,andbookedanappointmentin 90seconds.
Youwillneverknowthishappened.Therewillbeno complaintform,noangryemail.Youhavelosther,and thousandslikeher,inasilentchurndrivenbythesingle mostneglectedpieceofyourinfrastructure:yourcontact center
Youcallitacontactcenter.Inreality,itisyourfrontdoor Andrightnow,yourfrontdoorisabroken,unwelcoming, anddeeplyfrustratingbarriertoentry.Youspendfortunes craftingapristineimageofclinicalexcellence,onlyto havethatimageshatteredbytheveryfirsthuman interactionapatienthaswithyourorganization.
Thisisnotanoperationalinconvenience.Itisaprofound strategicfailure.Thebeliefthatyoucandelivera21stcenturypatientexperiencethrougha20th-centuryphone systemisadelusionthatisactivelyerodingyourmarket share.
Today,wewillstopmakingexcusesforthisfailure.We willdissectyourbrokenfrontdoorandlayoutthe strategicplaybookfortransformingitfromyourbiggest liabilityintoyourmostpowerfulengineforpatient retentionandgrowth.
TheAnatomyofaBroken‘FrontDoor’
Let'sdiagnosethedisease.Yourlegacycontactcenteris sufferingfromthreecriticalcomorbiditiesthatarefamiliar toalmosteveryhospitalexecutiveIspeakwith.
1.TheBlackHoleExperience:Thepatientjourneyinto yourorganizationisaone-waytripintoablackholeof wastedtime.Theycall,theywait,theygettransferred, andtheyareforcedtorepeattheirname,dateofbirth, andreasonforcallingtoeverynewpersontheyspeak with.Thisprocessdoesmorethanjustfrustratethem;it communicatesadeepinstitutionaldisrespectfortheir timeandaddsalayerofadministrativeanxietytotheir existingmedicalconcerns.
2.ThePatchworkQuiltofConfusion:Youdonothaveonefront door;youhavetwenty Thereisadifferentnumberforthemain hospital,theorthopedicclinic,theimagingcenter,andthe billingoffice.Eachhasitsownmenu,itsownholdmusic,its ownprocess.Tothepatient,thisdoesnotfeellikeaunified healthsystem.Itfeelslikeadisorganizedcollectionof disconnectedbusinesses.Itsignalschaos.
3.TheData-VoidCommandCenter:Thisisthemostdamning symptom.Youhavenorealdataonhowyourfrontdooris performing.Youlikelydonotknowyouraveragewaittime, yourcallabandonmentrate,or,mostcritically,theactual reasons peoplearecalling.Youaremanagingbyanecdote.You onlyhearabouttheproblemswhenapatientisangryenoughto escalateacomplainttoyouroffice.Youareflyingblind, attemptingtomanageacriticalpieceofyourbusinesswithout anymeaningfulintelligence.
Thisisnotahypotheticalscenario.ConsiderJupiterMedical Center.Beforeoverhaulingtheirsystem,theywerelivingthis reality Theyhada“transformational”newEpicEHR,buttheir communicationsystemwasalegacyanchor.Itwas,intheirown words,nota“greatpatientsatisfier.”Theyrecognizedthedisease beforeitmetastasizedandtookdecisiveaction.Theyunderstood thatthemostadvancedclinicaltoolsareworthlessifthepatient givesupbeforeevengettinganappointment.
TheStrategicMandate:StopManagingCalls,Start OrchestratingJourneys
Tofixthis,youmustfundamentallyreframetheproblem.Your goalisnottoanswerphonecallsmoreefficiently.Yourgoalisto resolvepatientneeds,seamlessly,acrosstheirentirejourneywith yourorganization.
Thisrequiresyoutoabandontheideaofa“phone system”andembracetheconceptofamodern, cloud-basedpatientengagementplatform.
Thinkofitthisway:yourcurrentsystemisa narrow,rigidpipeline.Youforceevery patient—fromthe22-year-oldwhowantstousea chatbottothe78-year-oldwhowantstospeaktoa human—downtheexactsamepath.Itisaone-sizefits-allapproachthatfitsnooneparticularlywell.
Amodernengagementplatformisdifferent.Itisa hubthatunifieseverychannelofcommunication: voice,webchat,textmessage,andemail.The patientchoosesthechannelthatismostconvenient forthem.Andcrucially,thecontextoftheir interactionfollowsthem.Iftheystartwithachatbot andneedtoescalatetoahuman,theagentwho picksupthecallalreadyknowswhotheyareand whattheyneed.Theyneverhavetorepeat themselves.
Thisshiftfrommanagingcallstoorchestrating journeysisthesinglemostimportantstrategic decisionyoucanmakeforyourpatientexperience.
TheThreeCapabilitiesofaModernEngagement Platform
Whenyouadoptatrueengagementplatform,you acquirethreedistinctcapabilitiesthatareimpossible toreplicatewithalegacyphonesystem.
Capability1:Proactive,IntelligentOutreach
Youstopwaitingpassivelyforpatientstocontact youandstartmanagingtheircareproactively This isabouttakingcontrolofthepatientjourney Insteadofsufferingthefinancialandoperational painofpatientno-shows,youuseautomatedcallsor textmessagestoconfirmappointments.
Butitgoesfarbeyondsimplereminders.Youcan usethisoutboundcapabilitytoprovideautomated pre-opinstructions,deliverpost-opcheck-insto monitorrecovery,and“nudge”patientstoadhereto theirmedicationschedules.Thatnudgeisnotjusta nicefeature;ithasadirectfinancialandclinical impact.AsAWSexpertshavenoted,simple outreachcanreducepreventablehospital readmissionsbyasmuchas25%.
Foranaveragehospital,thatcantranslateintohundredsof thousandsofdollarsinsavings,nottomentiontheprofound impactonpatientoutcomes.
Capability2:TheEmpowered,EffectiveAgent
Yourpatient-facingstaff—youragents—areacriticalstrategic asset.Yet,yourcurrentsystemsetsthemupforfailure.You saddlethemwithwhatexpertscall“cognitiveoverload.”They mustnavigatemultiplescreens,togglebetweendifferent applications,andconstantlyaskthepatienttorepeat information,allwhiletryingtosoundempathetic.
Amodernplatformdestroysthisinefficiency Whenacall,chat, oremailarrives,itisdeliveredtotheagentina“singlepaneof glass.”Theagentinstantlysees:
· Whothepatientis:Theirnameandpatientrecordare automaticallydisplayed.
· Thecontextoftheirjourney:Thesystemshowsifthey werejustonthewebsitelookingataspecificdoctor's profileortryingtopayabill.
· Theirrecenthistory:Alogofpastinteractionsis immediatelyvisible.
Thisisnotaboutmakingtheagent’slifeeasier.Itisabout makingthembrutallyeffective.Iteliminatesthetimethey wasteonadministrativefumblingandallowsthemtofocus 100%oftheireffortonresolvingthepatient’sissuequicklyand compassionately Ahappy,effectiveagentcreatesahappy,loyal patient.
Capability3:TheSelf-ServiceEscapeHatch
Asignificantportionofyourinboundcallsarefrompatients withsimple,repetitivequestions.“Whatareyourvisiting hours?”“HowdoIgettotheimagingcenter?”“CanI reschedulemyappointment?”
Youarecurrentlypayingtrainedhumanagentstofunctionas low-levelsearchengines.Thisisagrossmisallocationof resources.
Amodernengagementplatformprovidesa24/7,AI-powered self-serviceoption.Intelligentchatbotscaninstantlyanswer commonquestions,processappointmentchanges,orhandle prescriptionrefillrequestswithoutanyhumanintervention. Thisistheescapehatchthatagrowingnumberofyourpatients desperatelywant.Theygetimmediatesatisfactionfortheir simpleneeds,whichfreesupyourhumanagentstohandlethe complex,nuanced,andhigh-empathyconversationswherethey createthemostvalue.
FromaBlackBoxtoaData-DrivenCommand Center
Perhapsthemosttransformativeaspectofthismodel istheshiftfromthedatavoidtoadata-richcommand center Acloud-basedplatformtrackseverything.
Youwillnolongerguess.Youwillknow.
Youwillhaveadashboardthatshowsyou,in real-time,yourpeakcalltimes,youraveragewait times,andyourabandonmentrates.Moreimportantly, youwilluseAI-poweredintentdetectionto understand why peoplearecontactingyou.Ifyousee that30%ofyourcallsarefrompatientsconfused abouttheirbillingstatements,younolongerjusthire moreagentstohandlethecalls.Youusethatdatato fixtherootcause:theconfusingbillitself.
Youcanevenusesentimentanalysistodetect frustrationinacaller’svoiceinreal-time,allowinga supervisortointervenebeforeasituationescalates. Youmovefrombeingreactivetoproactively managingthepatientexperiencewithalevelof precisionyoupreviouslycouldnotimagine.
YourFrontDoorIsaChoice
Letmebeclear Theexperienceyourpatientshave whentheytrytocontactyouisnotanaccident.Itisa choice.Everydayyouoperatewithyourlegacy system,youarechoosingtoprovideafragmented, frustrating,anddisrespectfulexperience.Youare choosingtoletpatientloyaltysilentlybleedoutof yourorganization.
Itistimetomakeadifferentchoice. Hereisyourdirective.Tomorrowmorning,askyour assistanttoperformasimpletest.Havethemcallyour mainhospitallinetoaskforthecontactinformation foraspecificdepartment.Then,havethemtryto scheduleanewpatientappointmentatoneofyour largestoutpatientclinics.Tellthemtotimetheentire processfromdialtoresolution.
Theresultofthatsimpletestwilltellyoueverything youneedtoknowaboutthestateofyourfrontdoor andtheurgencyofthismandate.Thetechnologytofix thisisnolongerneworexperimental;itisamature, accessible,andstrategicnecessity Theonlyremaining questioniswhetheryouhavetheleadershiptoact.
The Strategic Alchemist MENZO HAVENGA
on Building a Different Kind of Biopharma Partner
Thejourneyfromapromising biopharmaceuticalconceptinaresearchlab toalife-changingmedicinereachingpatients isfraughtwithchallenges.It’sapathdefinedby scientifichurdles,immensecapitalrequirements, complexregulatorylandscapes,andthedelicate processofscalingbiologicalmanufacturing.Formany biotechstart-upsandevenlargerpharmacompanies, navigatingthispipelineefficientlyisamake-or-break proposition.TheyoftenturntoContractDevelopment andManufacturingOrganizations(CDMOs),butthe relationshipcanbetransactional,lackingthedeep scientificandstrategicpartnershipneededtotruly accelerateinnovation.
ThisisthegapMenzoHavenga,PresidentandCEO ofBataviaBiosciences,setouttofill.Amolecular virologistbytrainingwithnearlythreedecadesof experienceinbiopharmaceuticalR&Dand management,Havengarecognizedtheneedfora differentkindofpartner–onethatactsnotjustasa serviceprovider,butasastrategicguideand technologicalinnovatorembeddedwithintheclient’s journey.Hispersonalmantra,“Betterownhalfof somethingthanallofnothing,”hintsatthe collaborative,value-sharingphilosophythatunderpins Batavia’smodel.
FromResearchScientisttoEntrepreneurialLeader
Havenga’strajectoryprovidesacompellingcasestudy inleveragingdeeptechnicalexpertiseintostrategic businessleadership.AfterearninghisPhD,hecuthis teethasaseniorscientistatIntroGene(laterCrucell), contributingsignificantlytofoundationaltechnologies likeadenoviralvectors–aplatformfamouslyused yearslaterbyJohnson&JohnsonfortheirCOVID-19 vaccine,withHavengacreditedasaco-inventor.Rising throughR&DleadershiprolesatCrucell,hegained
crucialexperiencemanaginglargescientific organizationsandnavigatingthecomplexitiesof corporateacquisitionsinthebiopharmaspace.
Hisentrepreneurialpivotcamein2010.Recognizingan opportunitytoofferspecializedbioprocessdevelopment expertiseoutsidetheconfinesofalargepharma company,hepartneredwithChrisYalloptospinBatavia BiosciencesoutoftheTNOorganization,aDutch appliedresearchinstitute.Thisspin-outitselfembodied the“ownhalf”philosophy,leveragingTNO's infrastructureandinitialsupportwhilegainingtheagility ofanindependententity.
BuildingaDifferentiatedValueProposition
BataviaBioscienceswasconceivednotasahigh-volume, low-costCDMO,butasacenterofexcellenceoffering high-qualityservicesforearly-stagebiopharmaceutical development.Theirinitialfocusspannedeverythingfrom DNAcloningandcelllinedevelopmenttoprocessscaleupandproductcharacterization.However,thestrategic visionquicklyexpandedbasedondirectclientfeedback.
ListeningintentlytotheneedsoffoundersandCEOs navigatingtheperilous“benchtoclinictomarket” pathway,Bataviarealizedclientsrequiredmorethanjust isolatedservices.Theyneededapartnerwhounderstood theentireproductdevelopmentlifecycle,includingthe inherentrisksandstrategicdecisionsateachstage.This ledtothedevelopmentoftheir‘ProductDevelopment Plan’(PDP)servicespackage–essentiallya comprehensivebusinessplantailoredtotheclient’s specificproduct,coveringmanufacturing,clinical, regulatory,IP,andcommunicationstrategies.Thismove transformedBataviafromaserviceproviderintoa strategicthoughtpartner,offeringalevelofguidance typicallyreservedforin-houseexpertiseorhigh-level consultants.
CentraltoBatavia’sdifferentiationisits investmentinproprietarytechnology platformsdesignedtotacklespecific,highimpactchallengesinbiopharmaceutical ® manufacturing.TechnologieslikeSTEP ® (improvingproductyield),SCOUT ® (enhancingscale-up),andHIP-Vax offer clientstangibletechnicaladvantages, savingtimeandreducingcostsin developmentandmanufacturing. Combinedwithaccesstoadiversearrayof viralvectorsystemsandcelllines,Batavia providesalevelofintegratedexpertiseand technologicalcapabilitythatdistinguishes itfrommanycompetitorswhooffermore commoditizedservices.
NavigatingtheGrowthCurve:Strategic PivotsandScaling
Batavia’sjourneyfromasmallspin-outto asignificantplayerisatestamentto strategicadaptabilityandbolddecisionmakingdrivenbymarketdemand.Starting withjust7employeesand300square metersoflabspace,thecompanyrapidly attractedclientsbasedonthedeep experienceofitsstaffandthequalityofits initialservices.
Respondingtothisdemandrequiredrapid scaling.TNO’sinitialflexibilityin accommodatingmultiplelabexpansions wascrucial.Apivotalstrategicmovecame in2011,justayearafterlaunch,withthe acquisitionofXendoPharmaServices. Thisbroughtin117highlytrained professionals,providinganimmediate, significantinjectionofhumancapitaland expertise,acceleratingthecompany’s growthfarbeyondwhatorganichiring alonecouldachieve.
Anothercriticaljuncturearrivedin2012 when,againdrivenbyclientneeds, Bataviaundertooktwomajorexpansions simultaneously:establishingasubsidiary inBostontoaccessthevitalUSbiotech ecosystemandaddingGood ManufacturingPractice(GMP) manufacturingservicesintheNetherlands.
Menzo Havenga President and CEO
Batavia Biosciences
ThedecisiontomoveintoGMPwas particularlysignificant,requiringsubstantial investmentinqualitysystems,expertstaff (QC,QA,QP),andfacilities.Havengaand histeaminitiallyaddressedthefacilityneed throughacleverstrategyofleasingGMP spaceonaproject-by-projectbasis,enabling themtobegindeliveringclinicalproductsand validatethemarketdemandbefore committingtobuildingtheirownlarge-scale facility(acapabilitytheyareaddingbylate 2025withanewcommercialproduction facility).Thisiterativeapproachtocapitalintensiveexpansionmitigatedriskwhile allowinggrowth.
Thefinancialresultsunderscorethesuccess ofthesestrategicmaneuvers.Bataviahas demonstratedstrongyear-on-yearrevenue growth(approx.33%CAGR),scalingfrom €1Matlaunchtosubstantiallyhigherfigures, attractingadiverseclientbaseincludinga significantportionofnon-profitandglobal healthorganizations–areflectionofthe company’sunderlyingmissiontocontribute totheaffordabilityandaccessibilityof medicines.Their97%successrateinGMP projectsisakeymetrichighlighting operationalexcellenceandthequality outcomesderivedfromtheirintegrated model.
TheLeadershipEquation:Plan,Dive,and Partner
Beyondstrategyandtechnology,Menzo Havengaemphasizesthatpeoplearethecore ofBatavia’ssuccess.Heattributesthe company’shighpercentageofreturning clientstothehardwork,dedication,and experienceofthestaff,enablingthe “customerintimacy”model.Attractingand retainingtoptalentinthecompetitive biopharmaspaceisachievednotjustthrough competitivecompensation,butbyoffering compelling,purpose-drivenwork–projects contributingtoglobalhealth,vaccine affordability,orimprovingliveswithgenetic conditions.Flexibility,careerplanning,and continuoustrainingareviewedascritical investmentsinhumancapital.
Havenga’sleadershipphilosophyisdistilled intopowerful,actionabletenets.“Planyour diveanddiveyourplan”underscoresthe importanceoffocusedexecutiononcea strategicdirectionisset–acruciallessonfor entrepreneursnavigatingcountless distractions.Finding“therightpeopleto followthedream”highlightstheabsolute necessityoftalentacquisitionandteam building.Being“honestabouttherisksand rewards”andbuilding“win-winsituations” speakstothetransparentandcollaborative approachneededtoattractsupporters, partners,andinvestorsthroughoutthe challengingscale-upphase.Hisinitial“Better ownhalfofsomethingthanallofnothing” philosophyisevidentinthesuccessfulspinoutstructure,thecollaborativeclient relationships,andthestrategicdecisionpoints alongBatavia’sgrowthpath,culminatingin thecompany’ssaletoCJCheilJedang corporationin2021–amovethatlikely providedresourcesforfurtherexpansionand marketreach.
Inanindustrygrapplingwithacceleratingthe paceofinnovationwhileensuringqualityand accessibility,companieslikeBatavia Biosciences,ledbystrategicthinkerslike MenzoHavenga,offeravaluablemodel.By combiningdeepscientificexpertisewitha strategic“thoughtpartner”approach,investing indifferentiatingtechnologies,andprioritizing humancapitalandcollaborativerelationships, theyarenotjustparticipatinginthebiopharma ecosystem;theyareactivelyhelpingtoshapea moreefficient,effective,andultimatelymore patient-centricfuture.Batavia’sjourney providesapotentcasestudyinhow specializedexpertise,strategicallyapplied,can createsignificantvalueandimpactonaglobal scale.
Build
THEIR OWN IDP Why Smart Leaders Don’t
(And What They Do Instead)
There’sareasontheworld’stopCEOs don’tbuildtheirownpayrollsoftware, CRMs,orsecuritystacksfromscratch. Theybuywhatworks—fast,proven,and scalable.
IntelligentDocumentProcessing(IDP)fallsinto thesamecategory Youdon’tbuilditunlessyour businessisinthebusinessofbuildingIDP. Otherwise,you'rebleedingcashandtimeon somethingyoucouldhavedeployedweeksago.
Yeteverymonth,someambitiousteamsetsoutto buildtheirownIDP—connectingAPIs,finetuningmodels,assemblingdashboards—onlyto realizesixmonthslaterthey’veburnedamillion dollarsandhaveademo,notasolution.
Ifyou’reevenaskingthe“buildvs.buy”question forIDP,here’syourrealitycheck.
What’sActuallyatStakewithIDP
Let’slevel-set.
IntelligentDocumentProcessingiswhatlets businessesextractstructureddatafrom unstructureddocuments—invoices,contracts, emails,forms,insuranceclaims,PDFs.Anywhere there’safile,IDPiswhatletsyoupullsignalfrom noise.
Inshort:it’sthebloodstreamofAI-enabled operations.
AndtheIDPmarketisn’tsomefringeusecase— it’scompoundingat29%peryear.By2032,we’re lookingatanindustryworthnearly$18billion.
Thatkindofmomentumdoesn’tcomefromniceto-haves.Itcomesfromeveryseriousenterprise realizing:“We’rewastinghoursanddollarson documentsnohumanwantstoread.”
ThemovetoIDPisobvious.
What’snotobvious—atleasttosometeams— ishowtoadoptitwithoutsettingtheircompany onfire.
TheAllureofBuildingItYourself
The“build”campalwaysstartsthesameway: smartengineers,eagertostitchtogetheranIDP systemusingoff-the-shelfAPIs.
“We’ll use OpenAI for language, something opensource for layout detection, wrap it in a dashboard, and fine-tune for our use cases.”
Intheory,thatsoundsclean.
Inpractice,here’swhathappens:
· Youspend6–12monthscobbling components.
· YouneedataskforceofAIengineers, annotators,opsleads,andDevSecOpsto maintainit.
· Youdiscoverthatfoundationalmodelsdon’t knowyourdocumentschema—andnowyou needexpensivepromptengineering,tuning, orcustomdatasets.
· Youdon’tactuallyautomateanything becauseyou’restuckvalidating40%of outputs.
· Youstartbuildingtoolstomaintainthetools.
Eventually,someoneasks, “Why are we building infrastructure for a commodity problem?”
Andnobodyhasagoodanswer.
RealityCheck:BuildingIDPCostsMoreThanYouThink
Let’swalkthroughtherealcostdriversofbuildingIDPin-house:
1.YouNeedSpecialistAITalent—Constantly
Thesearenotjustdatascientists.Youneedpeoplefluentin:
· Documentlayoutanalysis
· NLPpipelines
· FoundationmodelAPIsandlimits
· OCRtuninganderrorcorrection
· Post-processingworkflows
· Governanceframeworks
They’reexpensive.They’rerare.Andtheyleavefast.
2.AccuracyIsYourProblemForever
Everyusecaseyousupport—invoiceextraction,legalclause parsing,insuranceclaimtriage—requiresitsownperformance tuning.
Mostfoundationalmodelsaretrainedongeneral-purposedata. Yourdocumentsareprobablynothingliketheonesintheirtraining set.
Thismeans:
· Moreannotation
· Morepromptengineering
· Moreerrorhandling
· Moremanualreview
Youareneverdone.
3.YouInheritGovernanceHeadaches
WithgreatAIcomesgreatresponsibility:
· Howdoyouversionyourmodels?
· Whathappenswhenperformancedropsinoneregion?
· Howdoyoutrackandauditpredictions?
· Canyouprovecomplianceinregulatedindustries?
Whenyoubuildityourself,theseareyourproblems.
Youdon’tjustownthesystem.Youownitsfailure modestoo.
SoWhyDoPeopleStillTrytoBuild?
Becausethere’samyth:thatbuildingischeaperand givesyoucontrol.
Intheory,yes.Inreality,itrarelyworksoutthatway
Cheaper?Notwhenyoufactorinthetalent,the maintenance,theramp-uptime,thetechnicaldebt.
Morecontrol?You'llcontroleveryoutage,bug,and missedSLAyourself.Goodluckscalingthat.
Meanwhile,yourcompetitorsarealreadyshipping productsusingprebuiltIDPthatjustworks.
WhatSmartCompaniesDoInstead
Smartleadersdon’tbuildIDPfromscratch.
Theybuyitfromvendorswho’vealreadysolved 90%oftheproblemandspendtheirtimefocusingon the10%that’suniquetotheirbusiness.
Therearetwogoodoptions:
1.BuyIDPasastandalonepointsolution
2.Buyitembeddedwithinalargerautomation platform
Eitherway,you’restandingontheshouldersofa techstackthat'sbeenstress-testedbyglobal enterprises.
Here’swhatyougetwhenyoubuy:
1.TimetoValueinWeeks,NotQuarters
Youskipthe“build”phaseentirely.ModernIDP platformscomewith:
· Pretrainedmodels
· Out-of-the-boxintegrations
· Built-infeedbackloops
· Professionalservicesandsupport
Youcangoliveinunderamonth—notjustwitha workingmodel,butwithresultsyourCFOcansee.
2.Low-CodeTrainingThatAnyoneCanUse
NoPhDsrequired.
Best-in-classIDPletsbusinessusersannotate,correct,and improvemodelsonthefly.Thesystemlearnsfromrealworldfeedback.
Someevenuseactivelearning,wheretheAIasksforhelp onlywhenuncertain—optimizingbothaccuracyand labor
3.RiskIsOffloadedtotheVendor
Governance,monitoring,modelupdates—allthe annoyingstuffisnowsomeoneelse’sresponsibility.
Yougetuptimeguarantees.YougetSOC2compliance. Yougetredresswhenthingsgowrong.
Andwhennewmodelshitthemarket?Yougettheupgrade.
4.Built-InScale
NeedtoexpandfrominvoicestoHRfiles?Fromlegal documentstocustomerchats?
Prebuiltplatformsalreadysupportmultipleformats,use cases,andgloballanguages.
Youdon’tbuildnewmodels.Youextendexistingones.
Thisisn’tjustscale.It’scompoundingreturns
WhyThisMattersMoreThanEver
In2025,AIstrategyisnotoptional.Ifyourdocumentsare stillstuckinPDFsandemails,you’releavingmoney,time, andinsightonthetable.
Buttheworstmoveisn’ttodelayIDP.
It’stobuildyourownanddelayeverythingelse.
EverydollaryouspendreinventingtheIDPwheelisa dollarnotspentoncustomerexperience,product innovation,ormarketexpansion.
Speedwins.Precisionscales.Claritybeatscontrol.
That’stherealcalculusbehindIDP
FinalWordfromtheTrenches
Ifyourcompany’scorebusinessisnotdocumentAI,don’t pretenditis.
Buythesystem.Customizethe10%thatmatters.Focus yourenergywhereitcounts.
Andifyou’rechoosingavendor,don’tbeswayedbyflashy demosorbiglogos.
Askonequestion: Whoownstheriskwhenthisbreaks?
Iftheansweris“notus,”you’reintherightplace.
Morten Olesen Founding Partner
There’saquietrevolutionbrewinginthe pharmaceuticalworld.Itdoesn’tinvolveablockbuster newdrugoragleaming,billion-dollarresearchlab. Instead,ithingesonsomethingfarmorefundamental,yet deceptivelycomplex:truth.Or,asMortenOlesen,the thoughtfulfoundingpartnerofCIMS,wouldputit,“data integrity.”It’saphrasethatmightsounddry,perhapsevena littleanodyne.Butinthehigh-stakesgameofdeveloping medicinesthatwilltouchmillionsoflives,theunassailabletruth ofdataisn’tjustimportant;it’sthebedrockuponwhich everythingelse–safety,efficacy,trust–isbuilt.
OlesenhasaKierkegaardianphilosophythatunderpinshis company’smission,adecidedlyDanishapproachtoaglobal challenge:“Ifoneistrulytosucceedinleadingapersontoa specificplace,onemustfirstandforemosttakecaretofindhim whereheisandbeginthere.”Forpharmaceuticalcompanies navigatingthelabyrinthinepathofclinicaldrugdevelopment, “wheretheyare”isoftenaplaceofoverwhelmingdata,a cacophonyofinformationwherethesignalofgenuineinsight canbeeasilylostinthenoiseofmismanagement.“Decisions basedonlow-qualitydata,”Olesenstateswiththecalm assuranceofamanwhohaswitnessedthealternative,“canlead tomismanagement.”It’sapoliteunderstatementforpotentially catastrophicoutcomes.
Imagine,foramoment,thejourneyofanewdrug.It’snota linearsprintbutagruelingmarathon,involvingcountless researchers,clinicians,andpatients,generatingmountainsof dataateverystep.Everybloodtest,everypatient-reported outcome,everymanufacturingvariable–itallbecomespartof anenormous,sprawlingpuzzle.Inthislandscape,CIMS emergesnotjustasaserviceprovider,butasakindofdata
cartographer,chartingacoursefromchaostoclarity. Theyspecializeinclinicaldataintegration,afieldthat soundstechnicalbecauseitis,butatitsheart,it’s aboutmakingsenseofthedeluge.
Thinkofitlikethis:intheoldworld,information trickled.Today,itfloods.Andwhilemoredata should meanbetterdecisions,itoftenjustmeansmore opportunitiestogetthingswrong.Asingleflaweddata pointinavastdatasetcanbethebutterflywingthat triggersahurricaneofwastedresources,delayed therapies,anderodedtrustwithregulatorybodieslike theFDAorEMA.ThisiswhereCIMS’sdedicationto dataintegrity,inspiredbyISO9001:2015risk-based thinkingandwhattheycallthe“3*Tframework” (Truth-Trust-Traceability),becomesparamount.They don’tjustmanagedata;theycurateit,ensuringit’s accurate,validated,and,crucially,verifiable.It’sabout buildingasupplychain,notforphysicalgoods,butfor informationitself–anInformationSupplyChain Management(ISCM)systemwhereeverylinkis fortifiedagainsterrorandambiguity
Thisisn’tjustabouttickingregulatoryboxes,though that’sasignificantpartofit.Robustdataintegrity, Olesenrightlypointsout,can“reducethefrequencyof audits,”savingcompaniesinvaluabletimeandmoney Butthebiggerwinistheconfidenceitinstills–confidencethatthelife-alteringdecisionsbeingmade arebasedonafoundationofunshakeablefact.CIMS achievesthisthroughasuiteoffivestandardizedtools, meticulouslydesignedforkeyregulatoryoperations fromvendormanagementtoaudits.Theresult? Streamlinedprocessesand,often,significantcutsin trialexecutiontime.It’stheKaizenprincipleof continuousimprovement,appliedtotheveryDNAof drugdevelopment.
TheSweetSpot:AGlimpseintotheFuturewith GLUCARE
Theabstractchallengeofdataintegrityfindsa tangible,andprofoundlyhuman,expressionin projectslikeGLUCARE.Here,thestakesare intenselypersonal:managingdiabetes,acondition affectingastaggering463millionpeopleworldwide. Currentcontinuousglucosemonitors(CGMs)area marvel,buttheyhaveashelflife,typicallyupto180 days,necessitatingrepeatedsurgicalreplacements. Thisisn’tjustinconvenient;it'scostly(around€3000 perpatientannually)andcarriesinherentrisks.
TheGLUCAREconsortium–apowerhousecollaboration includingZimmer&PeacockfromNorway,SafeImplant TechnologyApS(SIT)fromDenmark,andAalborg University–isaimingforaparadigmshift.Theiraudacious goal,backedbya€1.3millionEurostarsgrant,istodevelop thefirstlong-term(over two years)implantablebiosensor forCGM.Thisisn’tjustanincrementalimprovement;it’sa leap.Centraltothisambitionisanovelsurfacecoating, GP5,patentedbySIT,designedtodramaticallyreducethe body’snaturaltendencytorejectforeignobjectsand improvesubcutaneousresidencytime.
Butbuildingsuchadeviceisanorchestraofexpertise. Microsensorengineersmustdesignsensorsofexquisite precision.Circuitdesignerscrafttheelectronics.Software programmersdevelopalgorithmstointerpretthedata. Medicalchemistsensurebioactivecompoundsremain stable.Immunologistsstudythebody’sresponse.And weavingthroughitall,likeagoldenthread,istheabsolute necessityforrobustdatamanagement.“Robustdata managementandintegrityprotocols,”theconsortiumstates, “areessentialforthesuccessofGLUCARE,relyingon collaborationandseamlessdataintegrationateverystage.” Everydatapoint,frompreclinicalanimalmodelstudiesto theeventualhumantrials,mustbepristine.TheGLUCARE projectisn’tjustaboutabetterdevice;it’satestamentto howcriticalunimpeachabledataistomedical breakthroughs.
TheNextFrontier:PersonalizedMedicine’sData Imperative
IfGLUCAREoffersasnapshotofcurrentinnovation, MortenOlesenandCIMSarealsolookingfurtherahead, towardsafuturedominatedbypersonalizedmedicine.The oldmodelof“one-size-fits-all”drugdiscoveryis,frankly, runningoutofsteam.“Thepharmaceuticalindustryfaces significantchallengesastraditionaldrugdiscoverypipelines aredryingout,”Olesenobserves.Theanswer,heandmany othersbelieve,liesintailoringtreatmentstotheindividual.
Antibodiesareleadingthischarge,theirspecificitymaking themidealcandidatesfortherapiesdesignedarounda patient’suniquebiologicalmakeup.Buttrue personalizationdemandsmorethanjustatargeteddrug.It requiresreal-timemonitoringofahostofpatientparameters –bloodpressure,glucose,andbeyond–andtheabilityto adjusttreatmentsonthefly.Imagineaworldwhereyour medicationisn’tafixeddosetakenatfixedintervals,buta dynamicresponsetoyourbody’sever-changing state.
Thisiswherethevisionbecomestruly transformative.Connectedmonitoringdevices talkingseamlesslytomedicationadministration devices.AI-drivenalgorithmscontinuously learningandoptimizingtreatment,minimizing thosedreadedadversedrugreactions(ADRs)that canderaileventhemostpromisingtherapies. Considerdiabetesagain:areal-timeglucose monitordirectlyinstructinganinsulinpump, maintainingperfectequilibrium,preventingthe dangerouspeaksandtroughsofbloodsugar
Thelinchpinforthisentirevision?Youguessedit: dataintegrity.“Continuousandaccurate measurementofpatientparametersisessential,” Olesenstresses.Withoutit,thepromiseof personalizedmedicineremainsjustthat–a promise.
Thechallengesareimmense,ofcourse.Developing reliable,non-invasive(orlong-termimplantable) monitoringdevicesisaHerculeantask.Thehuman immunesystem,evervigilant,tendstoencapsulate implants,dullingtheirsensitivity–aproblemthat oftenrearsitsheadwithintendays.Integrating thesedeviceswithadministrationsystems, developingthesophisticatedAI,ensuring cybersecurity–thelistislong.
Yet,thisispreciselythefrontierwherecompanies likeCIMS,withtheirdeepexpertiseindata managementandtheirphilosophicalcommitment tostarting“wheretheclientis,”become indispensable.TheircollaborationwithSafe ImplantTechnologyontheGLUCAREprojectis morethanjustasingleventure;it’safoundational steptowardsthisbroadervisionofconnected,datadriven,personalizedhealthcare.
Thejourneyfromasingledatapointtoalifesavingtherapyisfraughtwithcomplexity.Butby focusingontheimmutabletruthencodedwithin thatdata,bymeticulouslyensuringitsintegrity frominceptiontoapplication,MortenOlesenand CIMSarenotjustmanaginginformation.Theyare helpingtobuildafuturewheremedicineissafer, moreeffective,andultimately,morehuman.Inthe relentlesspursuitofhealth,itturnsoutthatthe mostpowerfultoolmightjustbetheunwavering commitmenttogettingthestoryright,onedata pointatatime.
MISS AN ISSUE
